静脉与皮下免疫球蛋白相关湿疹反应可见于多种免疫球蛋白类型:法国全国多中心研究
该法国回顾性描述性研究纳入322例患者,发现免疫球蛋白相关湿疹多见于男性(78.9%)和神经系统疾病患者(76%),以出汗不良性湿疹(32.7%)和干燥性掌跖湿疹(32.6%)为主,5%出现红皮病。62%的湿疹发作发生在首次免疫球蛋白疗程后,涉及13种静脉或皮下免疫球蛋白类型,维持原治疗者复发率84%,更换类型者复发率68%。
要点
- 免疫球蛋白相关湿疹可见于13种静脉或皮下免疫球蛋白类型,男性及神经系统疾病患者多见。
- 62%的湿疹发作发生于首次免疫球蛋白疗程后,维持原治疗者复发率84%,更换类型者复发率68%。
- 停用免疫球蛋白后30%患者仍有持续性湿疹。
核心结论
- 免疫球蛋白相关湿疹可见于所有免疫球蛋白类型,多见于需要长期免疫球蛋白治疗的神经系统疾病患者。
- 复发频繁,即使更换免疫球蛋白类型后仍可复发,当需要维持免疫球蛋白治疗时可能造成治疗困境。
研究设计与样本
- 法国全国多中心回顾性描述性研究,查询法国国家药物警戒数据库,并向皮肤科医生发出全国病例征集,共纳入322例患者。
主要发现
- 湿疹多见于男性(78.9%)和因神经系统疾病治疗的患者(76%)。
- 临床表现主要为出汗不良性湿疹(32.7%)和干燥性掌跖湿疹(32.6%),5%的病例出现红皮病。
- 62%的湿疹发作发生在首次免疫球蛋白疗程后。
- 湿疹可见于13种静脉或皮下免疫球蛋白类型。
- 维持相同治疗的患者中84%复发,更换免疫球蛋白类型的患者中68%复发。
临床怎么用
- 原文未据此给出推荐。
局限性
- 回顾性研究,可能存在数据缺失或回忆偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human immunoglobulins are used for treating diverse inflammatory and autoimmune disorders. Eczema is an adverse event reported but poorly described. OBJECTIVES: To describe the clinical presentation, severity, outcome, and therapeutic management of immunoglobulin-associated eczema. METHODS: This retrospective and descriptive study included a query of the French national pharmacovigilance database, together with a national call for cases among dermatologists. RESULTS: We included 322 patients. Eczema occurred preferentially in men (78.9%) and in patients treated for neurological pathologies (76%). The clinical presentation consisted mainly of dyshidrosis (32.7%) and dry palmoplantar eczema (32.6%); 5% of cases exhibited erythroderma. Sixty-two percent of the eczema flares occurred after the first immunoglobulin course. Eczema was observed with 13 intravenous or subcutaneous immunoglobulin types and recurred in 84% of patients who maintained the same treatment and in 68% who switched the immunoglobulin type. After immunoglobulin discontinuation, 30% of patients still had persistent eczema. LIMITATIONS: Retrospective study, with possible missing data or memory bias. CONCLUSION: Immunoglobulin-associated eczema occurred with all immunoglobulin types, preferentially in patients with neurologic diseases who required prolonged immunoglobulin treatment. Recurrence was frequent, even after switching the immunoglobulin type, which can lead to a challenging therapeutic situation when immunoglobulin maintenance is required.
引用
- Voland P, Barthel C, Azzouz B, et al. Intravenous and subcutaneous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulin types: A French national multicenter study. J Am Acad Dermatol. 2022. PMID: 36252685. doi:10.1016/j.jaad.2022.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。